Cargando…
Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway
Although substantial studies on peroxisome proliferator-activated receptor γ (PPARγ) have focused on the mechanisms by which PPARγ regulates glucose and lipid metabolism, recent reports have suggested that PPARγ shows tumorigenic or antitumorigenic effects. The roles and mechanisms of PPARγ activati...
Autores principales: | Wu, Kai, Yang, Yang, Liu, Donglei, Qi, Yu, Zhang, Chunyang, Zhao, Jia, Zhao, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190119/ https://www.ncbi.nlm.nih.gov/pubmed/27323819 http://dx.doi.org/10.18632/oncotarget.10067 |
Ejemplares similares
-
Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells
por: DANG, LIFENG, et al.
Publicado: (2014) -
Effect of YAP1 silencing on esophageal cancer
por: Zhao, Jia, et al.
Publicado: (2016) -
PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008) -
Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells
por: Zhu, Dengyan, et al.
Publicado: (2019) -
Heme Oxygenase-1 Inhibits the Proliferation of Hepatic Stellate Cells by Activating PPARγ and Suppressing NF-κB
por: Yang, Hui, et al.
Publicado: (2022)